Medicine
Ga-68-DOTATOC 4 mCi/mL injection
Ga-68-DOTATOC 4 mCi/mL injection is a prescription medicine containing Edotreotide gallium ga-68 for intravenous use, marketed by UIHC P E T Imaging Center, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Ga 68 DOTATOC Injection upright in a lead shielded container at 25°C…
Key facts
- Active ingredient (INN)
- Edotreotide gallium ga-68
- Brand
- Ga-68-DOTATOC
- Strength
- 4 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 14 mL
- Marketing authorisation holder
- UIHC P E T Imaging Center
- Manufacturer
- UIHC P E T Imaging Center
- Origin register
- US FDA, United States
- Storage
- Store Ga 68 DOTATOC Injection upright in a lead shielded container at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store and dispose of Ga 68 DOTATOC Injection in accordance with the regulations and a general license, or its equivalent, of an Agreement State or a Licensing State.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V09IX09 Edotreotide gallium ga-68
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2019
- Identifiers
- DailyMed set ID c4d185c3-d520-462d-ba50-4f4ee485ace3NDC 24417-681Application NDA210828
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 14 mL in 1 vial, multi-dose | 24417-681-30 | UIHC P E T Imaging Center | 1 September 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Edotreotide gallium ga-68 is a prescription medicine indicated with positron emission tomography (PET) for the localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. MedsAcross supplies Edotreotide gallium ga-68 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Edotreotide gallium ga-68For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ga-68-DOTATOC prescribing information (UIHC P E T Imaging Center) · U.S. National Library of Medicine, DailyMed
Need Ga-68-DOTATOC 4 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.